Tocris Bioscience社 What's new at Tocris Bioscience?
この製品に関するご意見・ご照会・お問合せはこちら
Check out this month’s new product introductions from Tocris Bioscience. See below for a selection of our innovative new product releases or visit our website for the complete list.
Product Name |
Research Area/ Application |
Target |
Action |
BI dihydrochloride |
Fluorescence Imaging |
RNA in Living Cells |
Light-up Aptamer |
CAM 833 |
Cancer |
BRCA2-RAD51 Interaction |
Inhibitor |
Helianorphin-19 |
Neuroscience |
κ-Opioid Receptors |
Agonist |
NCT 02 |
Cancer/ Cell Cycle |
CDK12/ Cyclin K |
Molecular Glue Degrader |
Olaparib |
Cancer |
PARP-1 and 2 |
Inhibitor |
|
Live Webinar: Exploiting Tumor Hypoxia for Targeted Immunotherapy
March 3, 2022 @ 7 am PST / 10 am EST / 4 pm BST / 0 am JST
Speakers: Greg M. Delgoffe, Ph.D. Associate Professor, Department of Immunology, University of Pittsburgh James Arnold, Ph.D. Reader, School of Cancer and Pharmaceutical Sciences, King’s College London
|
|
Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。